Vericel looks to market a gel for burns with new $142M licensing deal
May 07, 2019 at 20:53 PM EDT
The Cambridge firm said Tuesday it will pay $17.5 million upfront and up to $125 million in milestones to license and sell the burn repair product NexoBrid from Israeli company MediWound Ltd.
